AGL Earnings Date: Nov 4, 2026 (Estimated) — Agilon Health, Inc.
NYSE · Healthcare · Medical Care Facilities
Updated
When is AGL's next earnings date?
Agilon Health, Inc. (AGL) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.23 on revenue of $1.46B.
How did AGL do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Agilon Health, Inc. posted EPS of $1.04 versus the $0.14 estimate, a beat of 642.9%. Revenue was $1.49B against a $1.45B estimate. The stock's 1-day post-earnings move was -19.5%.
How much does AGL stock move after earnings?
AGL beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 34.7% (up or down) in the day after earnings.
About Agilon Health, Inc.
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | 0.14 | 1.04 | +642.86% | $1.49B | ✅ Beat | -19.49% | -20.02% | -19.81% |
| 2026-05-06 | Q1 2026 | 0.95 | 1.80 | +89.47% | $1.42B | ✅ Beat | +117.81% | +158.56% | +247.76% |
| 2026-02-25 | Q4 2025 | -6.75 | -11.50 | -70.37% | $1.57B | ❌ Miss | +18.96% | +39.68% | -23.84% |
| 2025-11-04 | Q3 2025 | -0.16 | -0.27 | -68.75% | $1.44B | ❌ Miss | +4.09% | -14.53% | +0.55% |
| 2025-08-04 | Q2 2025 | -0.11 | -0.25 | -127.27% | $1.40B | ❌ Miss | -51.52% | -52.45% | -33.89% |
| 2025-05-06 | Q1 2025 | 0.01 | 0.00 | -100.00% | $1.53B | ❌ Miss | -23.99% | -39.46% | -52.91% |
| 2025-02-25 | Q4 2024 | -0.13 | -0.26 | -100.00% | $1.52B | ❌ Miss | -7.44% | -12.67% | +24.52% |
| 2024-11-07 | Q3 2024 | -0.11 | -0.29 | -163.64% | $1.45B | ❌ Miss | -34.05% | -38.71% | -19.71% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $1.49B total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Medical Services | 99.9% | $1.49B | +7.2% | $4.60B | $1.53B | $1.39B | $1.43B |
| Other Operating | 0.1% | $1.8M | -38.1% | $9.6M | $2.9M | $2.9M | $2.9M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.